These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6149907)

  • 1. The metabolism and excretion of buprenorphine in humans.
    Cone EJ; Gorodetzky CW; Yousefnejad D; Buchwald WF; Johnson RE
    Drug Metab Dispos; 1984; 12(5):577-81. PubMed ID: 6149907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces.
    Cone EJ; Gorodetzky CW; Yousefnejad D; Darwin WD
    J Chromatogr; 1985 Feb; 337(2):291-300. PubMed ID: 3838755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Huang W; Moody DE; McCance-Katz EF
    Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of buprenorphine in urine].
    Hegstad S; Christophersen AS; Khiabani HZ
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):184-5. PubMed ID: 18202730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
    Moody DE; Slawson MH; Strain EC; Laycock JD; Spanbauer AC; Foltz RL
    Anal Biochem; 2002 Jul; 306(1):31-9. PubMed ID: 12069411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry.
    McMillin GA; Davis R; Carlisle H; Clark C; Marin SJ; Moody DE
    J Anal Toxicol; 2012 Mar; 36(2):81-7. PubMed ID: 22337776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and application of a rapid gas chromatography-mass spectrometry method to monitor buprenorphine withdrawal protocols.
    George S; George C; Chauhan M
    Forensic Sci Int; 2004 Jul; 143(2-3):121-5. PubMed ID: 15240031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an Acetyl Derivative to Improve GC-MS Determination of Norbuprenorphine in the Presence of High Concentrations of Buprenorphine in Urine.
    Gervais JR; Hobbs GA
    J Anal Toxicol; 2016 Apr; 40(3):208-12. PubMed ID: 26811236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary excretion, metabolism and enterohepatic circulation of buprenorphine.
    Brewster D; Humphrey MJ; McLeavy MA
    Xenobiotica; 1981 Mar; 11(3):189-96. PubMed ID: 7293215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats.
    Ohtani M; Kotaki H; Uchino K; Sawada Y; Iga T
    Drug Metab Dispos; 1994; 22(1):2-7. PubMed ID: 8149883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas chromatographic-mass spectrometric quantitation of urinary buprenorphine and norbuprenorphine after derivatization by direct extractive alkylation.
    Lisi AM; Kazlauskas R; Trout GJ
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):67-77. PubMed ID: 9187385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair analysis for buprenorphine and its dealkylated metabolite by RIA and confirmation by LC/ECD.
    Kintz P; Cirimele V; Edel Y; Jamey C; Mangin P
    J Forensic Sci; 1994 Nov; 39(6):1497-503. PubMed ID: 7815029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of various derivatization approaches for gas chromatography-mass spectrometry analysis of buprenorphine and norbuprenorphine.
    Wu CH; Yang SC; Wang YS; Chen BG; Lin CC; Liu RH
    J Chromatogr A; 2008 Feb; 1182(1):93-112. PubMed ID: 18215395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant.
    Pontani RB; Vadlamani NL; Misra AL
    Xenobiotica; 1985 Apr; 15(4):287-97. PubMed ID: 4024663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry.
    Kronstrand R; Seldén TG; Josefsson M
    J Anal Toxicol; 2003 Oct; 27(7):464-70. PubMed ID: 14607001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples.
    Tracqui A; Kintz P; Mangin P
    J Forensic Sci; 1997 Jan; 42(1):111-4. PubMed ID: 8988582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation.
    Mégarbane B; Marie N; Pirnay S; Borron SW; Gueye PN; Risède P; Monier C; Noble F; Baud FJ
    Toxicol Appl Pharmacol; 2006 May; 212(3):256-67. PubMed ID: 16169027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry.
    Vincent F; Bessard J; Vacheron J; Mallaret M; Bessard G
    J Anal Toxicol; 1999; 23(4):270-9. PubMed ID: 10445490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple gas chromatography-mass spectrometry procedure for the simultaneous determination of buprenorphine and norbuprenorphine in human urine.
    Fuller DC
    J Anal Toxicol; 2008 Oct; 32(8):626-30. PubMed ID: 19007513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.